Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-11 Sale | 2024-04-15 7:05 pm | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 47,709 | $25.04 | $1,194,700 | 1,477,428 (Indirect Direct) | View |
| 2024-03-25 Sale | 2024-03-27 5:03 pm | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 12,000 | $17.56 | $210,661 | 1,525,137 (Indirect Direct) | View |
| 2024-02-26 Sale | 2024-02-28 5:14 pm | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 12,000 | $16.89 | $202,653 | 1,537,137 (Indirect Direct) | View |
| 2024-01-25 Sale | 2024-01-29 8:01 pm | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 12,000 | $15.69 | $188,229 | 1,549,137 (Indirect Direct) | View |
| 2023-12-26 Sale | 2023-12-28 4:29 pm | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 12,000 | $14.64 | $175,709 | 1,561,137 (Indirect Direct) | View |
| 2023-12-21 Sale | 2023-12-26 7:31 pm | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 8,195 | $13.05 | $106,915 | 1,889,862 (Indirect Direct) | View |
| 2023-12-20 Sale | 2023-12-21 4:31 pm | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 7,779 | $13.01 | $101,238 | 1,581,332 (Indirect Direct) | View |
| 2023-11-03 Sale | 2023-11-06 4:42 pm | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 8,026 | $13.08 | $104,999 | 1,589,111 (Indirect Direct) | View |
| 2023-09-25 Sale | 2023-09-26 7:37 pm | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 12,000 | $13.81 | $165,691 | 1,597,137 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-11 Exercise | 2024-04-15 7:05 pm | N/A 2030-06-16 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 47,709 | $0 | 1,477,428 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 7:05 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 47,709 | $1.12 | 1,477,428 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:03 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 12,000 | $0 | 1,525,137 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:03 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 12,000 | $1.12 | 1,525,137 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-28 5:14 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 12,000 | $0 | 1,537,137 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-28 5:14 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 12,000 | $1.12 | 1,537,137 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 8:56 pm | N/A 2034-02-12 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel PRESIDENT AND CEO | 410,000 | $0 | 410,000 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 8:01 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 12,000 | $0 | 1,549,137 (Direct) | View |
| 2024-01-25 Exercise | 2024-01-29 8:01 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 12,000 | $1.12 | 1,549,137 (Direct) | View |
| 2023-12-26 Exercise | 2023-12-28 4:29 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 12,000 | $0 | 1,561,137 (Direct) | View |
| 2023-12-26 Exercise | 2023-12-28 4:29 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 12,000 | $1.12 | 1,561,137 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-26 7:31 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 8,195 | $0 | 1,889,862 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-26 7:31 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 8,195 | $1.12 | 1,889,862 (Direct) | View |
| 2023-12-20 Exercise | 2023-12-21 4:31 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 7,779 | $0 | 1,581,332 (Direct) | View |
| 2023-12-20 Exercise | 2023-12-21 4:31 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 7,779 | $1.12 | 1,581,332 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-06 4:42 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 8,026 | $0 | 1,589,111 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-06 4:42 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 8,026 | $1.12 | 1,589,111 (Direct) | View |
| 2023-09-25 Exercise | 2023-09-26 7:37 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 12,000 | $0 | 1,597,137 (Direct) | View |
| 2023-09-25 Exercise | 2023-09-26 7:37 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 12,000 | $1.12 | 1,597,137 (Direct) | View |
| 2023-04-04 Option Award | 2023-04-06 8:30 pm | N/A 2033-04-04 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 452,000 | $0 | 452,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 9:33 pm | N/A 2030-06-15 | Enliven Therapeutics Inc. | ELVN | Kintz Samuel President and CEO | 1,924,969 | $0 | 837,444 (Direct) | View |